Abbott To Buy Starlims In $123M Cash Deal

Law360, New York (December 15, 2009, 5:29 PM EST) -- Abbott Laboratories Inc. will acquire information systems producer Starlims Technologies Ltd. for about $123 million in cash, in a deal the drugmaker says will strongly position it in the emerging field of health care informatics.

Under the deal, announced by the companies Monday, Abbott will acquire all outstanding equity in Starlims for $14 per share.

Abbott said the acquisition would help improve its position in the growing market for technologies that organize and help to interpret patient medical data, known as health care informatics, which Abbott...
To view the full article, register now.